机译:Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02215 USA;
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA;
Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Ctr Pesquisa Oncol, Porto Alegre, RSFukushima Med Univ, Fukushima, JapanUniv Ulsan, Coll Med, Asan Med Ctr, Seoul, South KoreaUniv Sao Paulo, Sao Paulo, BrazilGemeinschaftspraxis Haematol & Onkol Langen, Langen, GermanyYonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South KoreaAichi Canc Ctr Hosp, Nagoya, Aichi, JapanStanford Univ, Sch Med, Stanford, CA 94305 USAMcGill Univ, Jewish Gen Hosp, Montreal, PQ, CanadaUniv Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, BelgiumCtr Jean Perrin, Dept Biopathol, Clermont Ferrand, FranceGenentech Inc, San Francisco, CA 94080 USAF Hoffmann La Roche, Basel, SwitzerlandLudwig Maximilians Univ Munchen, Breast Ctr, Dept Gynecol & Obstet, Munich, Germany;